Correction: BMC Complement Med Ther 17, 338 (2017)
https://doi.org/10.1186/s12906-017-1846-5
Following publication of the original article [1], the authors identified an error in Fig. 3. The b4 of Fig. 3 in this published paper was wrongly used. The correct figure is given below.
Fig. 3.
Effect of XJEK on cardiomyocyte CSA and cardiomyocyte long axis of MI mice (HE stain, magnification×400). a Representative images of histological section of cardiomyocyte cross-section (HE staining, magnification×400); b Representative images of histological section of cardiomyocyte long axis (HE staining, magnification×400); c Quantitative analyses results (mean ± SEM, n=6–9). (1) Sham group; (2) Model group; (3) XJEK group; (4) Fosinopril group. * P<0.05, ** P<0.01 vs. Sham group; #P<0.05, ##P<0.01 vs. Model group
The original article [1] has been corrected.
Footnotes
Juan Hu and Yong-xue Zhang contributed equally to this work.
Reference
- 1.Hu J, Zhang Y, Wang L, et al. Protective effects of Xinji′erkang on myocardial infarction induced cardiac injury in mice. BMC Complement Altern Med. 2017;17:338. doi: 10.1186/s12906-017-1846-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

